IPM
PubChem Notes:
Imipenem Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.
Molecular Formula:
C12H19N3O5S
InChI: InChI=1/C12H17N3O4S.H2O/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17;/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19);1H2/t6-,7-,9-;/m1./s1/f/h18H,13H2;/b14-5+;
InChIKey: InChIKey=GSOSVVULSKVSLQ-MRCSPMPADY
SMILES: CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.O
Names:
D00206
Imipenem (JP15/USP)
imipenem
IPM
(5R,6S)-3-[2-(aminomethylideneamino)ethylsulfanyl]-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid hydrate
74431-23-5
Registries:
PubChem CID 5282372
PubChem ID 7847274
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|